RARE (ULTRAGENYX PHARMACEUTICAL IN) Institutional Ownership Summary
Based on the latest SEC 13F filings, 4 institutional investors hold RARE (ULTRAGENYX PHARMACEUTICAL IN) with a combined value of $285.94M across 12,432,071 shares. The largest holder is BlackRock, Inc. with a position worth $152.53M (0.00% of their portfolio). 3 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$285.94M
Total Shares Held
12,432,071
Institutional Holders
4
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $152.53M | 0.00% | +3.2% |
| 2 | BAKER BROS. ADVISORS LP | $63.77M | 0.37% | - |
| 3 | CITADEL ADVISORS LLC | $61.22M | 0.01% | +350.0% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $8.42M | 0.01% | +1571.7% |